HK Stock MarketDetailed Quotes

01528 RS MACALLINE

Watchlist
  • 1.530
  • -0.030-1.92%
Market Closed May 3 16:09 CST
6.66BMarket Cap-2045P/E (TTM)

RS MACALLINE Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
-19.30%2.11B
-18.55%11.51B
-17.25%8.68B
-18.64%5.66B
-22.47%2.62B
-8.86%14.14B
-7.67%10.48B
-7.28%6.96B
1.01%3.37B
8.97%15.51B
Operating income
-19.30%2.11B
-18.55%11.51B
-17.25%8.68B
-18.64%5.66B
-22.47%2.62B
-8.86%14.14B
-7.67%10.48B
-7.28%6.96B
1.01%3.37B
8.97%15.51B
Cost of sales
----
15.34%-4.48B
----
12.15%-2.04B
----
1.09%-5.29B
----
---2.32B
----
---5.35B
Operating expenses
21.26%-833.76M
15.34%-4.48B
12.82%-3.64B
12.15%-2.04B
18.58%-1.06B
1.09%-5.29B
0.38%-4.17B
15.09%-2.32B
-3.84%-1.3B
2.34%-5.35B
Gross profit
-17.97%1.28B
-20.48%7.03B
-20.18%5.04B
-21.89%3.62B
-24.90%1.56B
-12.95%8.84B
-11.93%6.31B
-2.80%4.64B
-0.69%2.07B
16.04%10.16B
Selling expenses
21.57%-201.72M
4.64%-1.48B
-7.65%-1.12B
-1.23%-606.24M
7.49%-257.18M
24.63%-1.56B
24.07%-1.04B
27.74%-598.85M
23.67%-277.99M
-21.83%-2.06B
Administrative expenses
17.49%-240.92M
5.33%-1.76B
-7.80%-1.05B
-8.92%-905.79M
17.44%-291.98M
25.21%-1.86B
27.94%-975.73M
5.72%-831.59M
8.50%-353.67M
-48.10%-2.49B
Research and development expenses
26.41%-3.66M
57.63%-19.63M
59.98%-13.77M
63.30%-9.37M
63.53%-4.97M
---46.33M
18.30%-34.41M
5.25%-25.52M
-7.43%-13.63M
----
Profit from asset sales
95.43%-21.31K
----
2,229.29%6.45M
----
-104.38%-466.76K
----
-102.18%-302.84K
----
5.91%10.65M
----
Revaluation surplus
-2,991.36%-324.39M
-113.00%-1.55B
-557.97%-456.77M
-30.83%-296.25M
-112.50%-10.49M
-194.19%-725.83M
-58.32%99.74M
-199.74%-226.43M
-59.84%83.93M
-149.93%-246.73M
-Changes in the fair value of investment property
----
----
----
----
----
----
----
----
----
---246.73M
-Changes in the fair value of other assets
-2,991.36%-324.39M
-113.00%-1.55B
-557.97%-456.77M
-30.83%-296.25M
-112.50%-10.49M
---725.83M
-58.32%99.74M
-199.74%-226.43M
-59.84%83.93M
----
Impairment and provision
-53.62%-69.7M
-238.41%-1.3B
-253.57%-741.12M
-48.85%-252.25M
-26.97%-45.37M
48.83%-385.21M
-22.03%-209.61M
-6.30%-169.47M
-48.08%-35.73M
-63.84%-752.84M
-Impairment of intangible assets
----
----
----
----
----
----
----
----
----
---219.59M
-Other impairment is provision
-53.62%-69.7M
-238.41%-1.3B
-253.57%-741.12M
-48.85%-252.25M
-26.97%-45.37M
27.76%-385.21M
-22.03%-209.61M
-6.30%-169.47M
-48.08%-35.73M
-16.05%-533.26M
Special items of operating profit
-228.65%-7.89M
-516.97%-881.04M
-30.45%144.95M
-162.70%-95.02M
-90.87%6.13M
-119.69%-142.8M
-65.04%208.41M
-71.68%151.54M
-50.13%67.2M
78.53%725.32M
Operating profit
-60.55%339.89M
-99.10%37.32M
-63.07%1.49B
-50.38%1.46B
-40.90%861.65M
-22.61%4.13B
-14.97%4.05B
-14.70%2.94B
-6.72%1.46B
-1.42%5.33B
Financing cost
-22.37%-644.51M
-6.04%-2.65B
-6.06%-1.88B
-0.51%-1.26B
7.71%-526.68M
7.10%-2.5B
6.14%-1.77B
-2.63%-1.25B
-0.11%-570.67M
-9.34%-2.69B
Share of profits of associates
----
6,227.03%65.3M
----
1,217.68%70.19M
----
-9.95%1.03M
----
--5.33M
----
--1.15M
Share of profit from joint venture company
----
145.18%12.41M
----
-40.51%18.57M
----
-162.35%-27.47M
----
--31.22M
----
--44.05M
Special items of earning before tax
-65.40%-54.4M
----
-2,775.61%-165.27M
----
-476.94%-32.89M
----
184.23%6.18M
----
-174.86%-5.7M
----
Earning before tax
-218.85%-359.02M
-258.96%-2.54B
-124.10%-549.74M
-83.26%288.2M
-65.74%302.08M
-40.48%1.6B
-20.36%2.28B
-22.53%1.72B
-11.89%881.6M
-4.62%2.68B
Tax
101.64%1.56M
96.05%-30.81M
91.00%-86.12M
77.07%-174.75M
61.62%-95.6M
-33.80%-780.77M
-34.23%-956.69M
-31.93%-762.18M
9.78%-249.12M
22.20%-583.54M
After-tax profit from continuing operations
-273.12%-357.45M
-414.66%-2.57B
-148.03%-635.87M
-88.18%113.45M
-67.35%206.47M
-61.11%816.88M
-38.45%1.32B
-41.65%959.75M
-12.69%632.48M
1.77%2.1B
Earning after tax
-273.12%-357.45M
-414.66%-2.57B
-148.03%-635.87M
-88.18%113.45M
-67.35%206.47M
-61.11%816.88M
-38.45%1.32B
-41.65%959.75M
-12.69%632.48M
1.77%2.1B
Minority profit
-64.19%14.06M
-214.02%-157.71M
-1,359.26%-75.34M
33.94%-14.75M
159.95%39.25M
0.90%138.32M
-93.05%5.98M
-116.50%-22.32M
-3,534.77%-65.47M
-58.90%137.08M
Profit attributable to shareholders
-322.16%-371.51M
-455.56%-2.41B
-142.53%-560.53M
-86.95%128.2M
-76.04%167.22M
-65.44%678.57M
-36.17%1.32B
-34.95%982.07M
-3.40%697.95M
13.47%1.96B
Basic earnings per share
-325.00%-0.09
-443.75%-0.55
-143.33%-0.13
-86.96%0.03
-75.00%0.04
-67.35%0.16
-43.40%0.3
-41.03%0.23
-15.79%0.16
11.36%0.49
Diluted earnings per share
-443.75%-0.55
-86.96%0.03
-67.35%0.16
0.23
0.49
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)
--
--
--
National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)
--
--
--
National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover -19.30%2.11B-18.55%11.51B-17.25%8.68B-18.64%5.66B-22.47%2.62B-8.86%14.14B-7.67%10.48B-7.28%6.96B1.01%3.37B8.97%15.51B
Operating income -19.30%2.11B-18.55%11.51B-17.25%8.68B-18.64%5.66B-22.47%2.62B-8.86%14.14B-7.67%10.48B-7.28%6.96B1.01%3.37B8.97%15.51B
Cost of sales ----15.34%-4.48B----12.15%-2.04B----1.09%-5.29B-------2.32B-------5.35B
Operating expenses 21.26%-833.76M15.34%-4.48B12.82%-3.64B12.15%-2.04B18.58%-1.06B1.09%-5.29B0.38%-4.17B15.09%-2.32B-3.84%-1.3B2.34%-5.35B
Gross profit -17.97%1.28B-20.48%7.03B-20.18%5.04B-21.89%3.62B-24.90%1.56B-12.95%8.84B-11.93%6.31B-2.80%4.64B-0.69%2.07B16.04%10.16B
Selling expenses 21.57%-201.72M4.64%-1.48B-7.65%-1.12B-1.23%-606.24M7.49%-257.18M24.63%-1.56B24.07%-1.04B27.74%-598.85M23.67%-277.99M-21.83%-2.06B
Administrative expenses 17.49%-240.92M5.33%-1.76B-7.80%-1.05B-8.92%-905.79M17.44%-291.98M25.21%-1.86B27.94%-975.73M5.72%-831.59M8.50%-353.67M-48.10%-2.49B
Research and development expenses 26.41%-3.66M57.63%-19.63M59.98%-13.77M63.30%-9.37M63.53%-4.97M---46.33M18.30%-34.41M5.25%-25.52M-7.43%-13.63M----
Profit from asset sales 95.43%-21.31K----2,229.29%6.45M-----104.38%-466.76K-----102.18%-302.84K----5.91%10.65M----
Revaluation surplus -2,991.36%-324.39M-113.00%-1.55B-557.97%-456.77M-30.83%-296.25M-112.50%-10.49M-194.19%-725.83M-58.32%99.74M-199.74%-226.43M-59.84%83.93M-149.93%-246.73M
-Changes in the fair value of investment property ---------------------------------------246.73M
-Changes in the fair value of other assets -2,991.36%-324.39M-113.00%-1.55B-557.97%-456.77M-30.83%-296.25M-112.50%-10.49M---725.83M-58.32%99.74M-199.74%-226.43M-59.84%83.93M----
Impairment and provision -53.62%-69.7M-238.41%-1.3B-253.57%-741.12M-48.85%-252.25M-26.97%-45.37M48.83%-385.21M-22.03%-209.61M-6.30%-169.47M-48.08%-35.73M-63.84%-752.84M
-Impairment of intangible assets ---------------------------------------219.59M
-Other impairment is provision -53.62%-69.7M-238.41%-1.3B-253.57%-741.12M-48.85%-252.25M-26.97%-45.37M27.76%-385.21M-22.03%-209.61M-6.30%-169.47M-48.08%-35.73M-16.05%-533.26M
Special items of operating profit -228.65%-7.89M-516.97%-881.04M-30.45%144.95M-162.70%-95.02M-90.87%6.13M-119.69%-142.8M-65.04%208.41M-71.68%151.54M-50.13%67.2M78.53%725.32M
Operating profit -60.55%339.89M-99.10%37.32M-63.07%1.49B-50.38%1.46B-40.90%861.65M-22.61%4.13B-14.97%4.05B-14.70%2.94B-6.72%1.46B-1.42%5.33B
Financing cost -22.37%-644.51M-6.04%-2.65B-6.06%-1.88B-0.51%-1.26B7.71%-526.68M7.10%-2.5B6.14%-1.77B-2.63%-1.25B-0.11%-570.67M-9.34%-2.69B
Share of profits of associates ----6,227.03%65.3M----1,217.68%70.19M-----9.95%1.03M------5.33M------1.15M
Share of profit from joint venture company ----145.18%12.41M-----40.51%18.57M-----162.35%-27.47M------31.22M------44.05M
Special items of earning before tax -65.40%-54.4M-----2,775.61%-165.27M-----476.94%-32.89M----184.23%6.18M-----174.86%-5.7M----
Earning before tax -218.85%-359.02M-258.96%-2.54B-124.10%-549.74M-83.26%288.2M-65.74%302.08M-40.48%1.6B-20.36%2.28B-22.53%1.72B-11.89%881.6M-4.62%2.68B
Tax 101.64%1.56M96.05%-30.81M91.00%-86.12M77.07%-174.75M61.62%-95.6M-33.80%-780.77M-34.23%-956.69M-31.93%-762.18M9.78%-249.12M22.20%-583.54M
After-tax profit from continuing operations -273.12%-357.45M-414.66%-2.57B-148.03%-635.87M-88.18%113.45M-67.35%206.47M-61.11%816.88M-38.45%1.32B-41.65%959.75M-12.69%632.48M1.77%2.1B
Earning after tax -273.12%-357.45M-414.66%-2.57B-148.03%-635.87M-88.18%113.45M-67.35%206.47M-61.11%816.88M-38.45%1.32B-41.65%959.75M-12.69%632.48M1.77%2.1B
Minority profit -64.19%14.06M-214.02%-157.71M-1,359.26%-75.34M33.94%-14.75M159.95%39.25M0.90%138.32M-93.05%5.98M-116.50%-22.32M-3,534.77%-65.47M-58.90%137.08M
Profit attributable to shareholders -322.16%-371.51M-455.56%-2.41B-142.53%-560.53M-86.95%128.2M-76.04%167.22M-65.44%678.57M-36.17%1.32B-34.95%982.07M-3.40%697.95M13.47%1.96B
Basic earnings per share -325.00%-0.09-443.75%-0.55-143.33%-0.13-86.96%0.03-75.00%0.04-67.35%0.16-43.40%0.3-41.03%0.23-15.79%0.1611.36%0.49
Diluted earnings per share -443.75%-0.55-86.96%0.03-67.35%0.160.230.49
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)------National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)------National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg